DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
9.25
-0.35 (-3.65%)
May 21, 2025, 3:37 PM - Market open
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $253.00 million as of May 21, 2025. Its market cap has increased by 96.74% in one year.
Market Cap
253.00M
Enterprise Value
246.99M
1-Year Change
96.74%
Ranking
Category
Stock Price
$9.25
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $253.00M, a decrease of -70.05%. That is a compound annual growth rate of -10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 262.90M | 341.11% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.96B |
| Johnson & Johnson | 369.43B |
| AbbVie | 325.62B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 292.24B |
| Abbott Laboratories | 234.86B |
| AstraZeneca | 215.95B |
| Novartis AG | 215.48B |